2
Announcements
Trials
Browse
Landscape
Status
Completed
83
Unknown
21
Recruiting
14
Active not recruiting
13
Terminated
11
Withdrawn
5
Not yet recruiting
2
No longer available
1
Sponsor Class
OTHER
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
trametinib
4
nilotinib
4
elotuzumab
4
dabrafenib
4
Amifampridine
4
regorafenib
3
pembrolizumab
3
midostaurin
3
fludarabine phosphate
3
fludarabine
3
Nivolumab
3
Lenalidomide
3
Ipilimumab
3
Everolimus
3
Dexamethasone
3
Cyclophosphamide
3
Crizotinib
3
Bortezomib
3
Axitinib
3
venetoclax
2
veliparib
2
tazemetostat
2
talimogene laherparepvec
2
navitoclax
2
gallium 68 PSMA-11
2
ceritinib
2
carbon-11 acetate
2
aldesleukin
2
Whole-Body Irradiation
2
Trabectedin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
Asparaginase
×
Clear all
NCT00590915
2026-01-23
EMTP
Phoenix Children's Hospital
No longer available